Creative Destruction Lab launched CDL-Cleveland with University Hospitals and Case Western Reserve University, creating a direct clinical integration platform aimed at moving biomedical startups from concept toward real hospital workflows. The new program is positioned as a structured bridge between early-stage biotech engineering and care delivery. The partnership model emphasizes embedding startups into hospital systems rather than relying on standalone pilots, aiming to shorten the distance between therapeutic innovation, validation, and clinician feedback. For biotech stakeholders, the initiative signals continued institutional interest in accelerating translation by pairing startup execution capacity with large-system clinical adoption pathways.